(This story has been updated).
The company said "managed revenue," a non-IFRS figure, rose 219% to $55.1 million. A company spokesperson said analysts' forecasts of $49.8 million were based on managed revenue.
The Wakefield, Mass.-based cannabis operator said its net loss was $24.4 million, or 5 cents per share, in the quarter ended June 30 vs. a loss of $6.4 million, or 1 cent, per share a year ago. Analysts were expecting a loss of 2 cents.
The company said the wider loss in the most recent quarter was due to an increase of $5.8 million in depreciation and amortization and an increase of $3.8 million in share-based compensation, both of which are non-cash.
There was also an increase of $4.4 million in one-time charges, primarily acquisition-related, among other expenses.
Adjusted EBITDA was $3.4 million compared to a loss of $3.8 million for the second quarter of 2018.
Curaleaf said that it currently operates in 12 states with 48 dispensaries, 14 cultivation sites and 13 processing sites.
Save 57% With Our Labor Day Sale. Join Jim Cramer's Action Alerts PLUS investment club to become a smarter investor! Click here to sign up